SUMMIT SPONSORS & EXHIBITORS
We are proud to partner with a diverse range of sponsors and exhibitors, each playing a crucial role in contributing to the success and richness of our event. Our sponsors, industry leaders in healthcare innovation, bring invaluable support and expertise that enhances the overall experience for attendees.
About Takeda
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline.
About AWS
Amazon Web Services (AWS) is proud to collaborate with EIT Health to meet the ongoing demand for digital skills around the globe. Since 2006, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. AWS works closely with healthcare organizations to help them unlock the power of their data from clinical notes to multi-modal data, and social determinants of health data to arrive at actionable insights to improve patient outcomes, lower costs, and improve efficiency.
AWS has made a commitment to develop the workforce to meet the demand for digital skills, and is investing millions of dollars to help train 29 million people around the world by the end of 2025.
About Boehringer Ingelheim
Boehringer Ingelheim is one of the 20 leading pharmaceutical companies worldwide. As part of the German pharmaceutical company Boehringer Ingelheim, the Boehringer Ingelheim Regional Center Vienna (RCV for short) bears business responsibility for more than 30 countries in Central and Eastern Europe and Central Asia. This makes RCV one of the Group's most important sites and also a flagship operation in the Austrian capital, where more than 3,000 people are employed.
Boehringer Ingelheim RCV GmbH & Co KG is one of the most important sites within the global group of companies. Vienna is the center of Boehringer Ingelheim's cancer research. Another focus is on the development and production of biopharmaceutical drugs, which we also manufacture for third-party suppliers. As a Regional Center, we are not only responsible for the Austrian market, but also serve a total of 33 countries.
Together, we pursue one goal: to achieve breakthroughs in the treatment of diseases and to advance the development of medicine.
About Pharmaron
Pharmaron is a premier service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 20,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China.
About Crowdhelix
Crowdhelix is a Global Innovation platform that forges links between an international network of excellent researchers and innovating companies, so that they can plan, deliver, and exploit pioneering collaborative projects and value chains. The platform uses proprietary software and machine learning to facilitate connections with a diverse community: RTOs (research & technology organisations), SMEs, start-ups, public institutions, corporations and investors.
About Bioindustry Park
Bioindustry park is a science park, specialized in Life Sciences, Human Health and Medical care. It promotes and develops Research and Innovation by hosting and supporting companies, start-ups and research institutions. It manages the regional innovation cluster, BioPmed. It offers tailored services to spin-off, start-ups and scale-ups, providing both labs and facilities in the campus as well as dedicated scientific, strategic and business support services to foster their go-to-market strategy and attract both, public and risk, capital.
